The proposed study is directed towards understanding the molecular mechanism of action of cannabinoids. It will seek to identify, within the cannabinoid structures, those molecular features required to produce the membrane perturbations that result in alterations of the cellular functions. The project will focus on a carefully selected group of cannabinoid analogs closely related in structure covering a wide range of potencies and will include detailed studies on: (a) the conformational properties of the cannabinoids in solution using high resolution NMR techniques; (b) the interactions of cannabinoids with representative phospholipid model membrane using 2H, 13C and 31P solid state NMR techniques; (c) the orientation of the cannabinoids in the model membranes, using 2H solid-state NMR; the topographical and geometrical features of the drug:membrane interactions using x-ray and neutron diffraction; the cannabinoid local environment in the membrane using high resolution NMR techniques for solids (MASS) and Fourier transform infrared; representation of the cannabinoid:membrane interactions based on information from our experimental findings using computer graphics. Studies analogous to (b) and (c) will be carried out with a biological membrane preparation (synaptosomal plasma membrane). Our findings wil be correlated with the effects of cannabinoids on the uptake of biogenic amines (norepinephine, dopamine, serotonin) by brain synaptosomes. Our studies will require extensive synthesis of specifically 2H- and 13C labeled cannabinoid analogs and phospholipids including a small number of novel cannabinoid analogs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA003801-07
Application #
3208482
Study Section
Special Emphasis Panel (SRCD (26))
Project Start
1985-01-01
Project End
1992-03-31
Budget Start
1991-01-01
Budget End
1992-03-31
Support Year
7
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Connecticut
Department
Type
Schools of Pharmacy
DUNS #
City
Storrs-Mansfield
State
CT
Country
United States
Zip Code
06269
Mallipeddi, Srikrishnan; Zvonok, Nikolai; Makriyannis, Alexandros (2018) Expression, Purification and Characterization of the Human Cannabinoid 1 Receptor. Sci Rep 8:2935
Yu, Tianqi; Ganapathy, Suthakar; Shen, Ling et al. (2018) A lethal synergy induced by phellinus linteus and camptothecin11 in colon cancer cells. Oncotarget 9:6308-6319
Schindler, Charles W; Scherma, Maria; Redhi, Godfrey H et al. (2016) Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys. Psychopharmacology (Berl) 233:1867-77
Pava, Matthew J; Makriyannis, Alexandros; Lovinger, David M (2016) Endocannabinoid Signaling Regulates Sleep Stability. PLoS One 11:e0152473
Parker, Linda A; Limebeer, Cheryl L; Rock, Erin M et al. (2016) A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models. Psychopharmacology (Berl) 233:2265-75
Schindler, Charles W; Redhi, Godfrey H; Vemuri, Kiran et al. (2016) Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys. Neuropsychopharmacology 41:2283-93
Guo, Jason J; Yang, De-Ping; Tian, Xiaoyu et al. (2016) 17?-estradiol (E2) in membranes: Orientation and dynamic properties. Biochim Biophys Acta 1858:344-53
Kulkarni, Shashank; Nikas, Spyros P; Sharma, Rishi et al. (2016) Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues. J Med Chem 59:6903-19
Tyukhtenko, Sergiy; Karageorgos, Ioannis; Rajarshi, Girija et al. (2016) Specific Inter-residue Interactions as Determinants of Human Monoacylglycerol Lipase Catalytic Competency: A ROLE FOR GLOBAL CONFORMATIONAL CHANGES. J Biol Chem 291:2556-65
Panlilio, Leigh V; Thorndike, Eric B; Nikas, Spyros P et al. (2016) Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats. Psychopharmacology (Berl) 233:1879-88

Showing the most recent 10 out of 192 publications